Advanced

Eben Moglen on Bilski, software patents, and big pharma

Posted by Scott_Ruecker on · Post a comment
The Prior Art; By Joe Mullin
Mail this story
Print this story

This interview is part of a series following the Supreme Court's Bilski decision, which left the laws on what you can get a patent on largely as they are, after a four-justice minority failed to ban "business method" patents. Columbia Law School professor Eben Moglen heads the Software Freedom Law Center (SFLC) and wrote the group's amicus brief in Kappos v. Bilski.

Full Story

  Nav
» Read more about: Story Type: Interview; Groups: Community, GNU

» Get new stories by e-mail: nightly or as they are published

« Return to the newswire homepage

  Related stories
» More like this

Comments

No comments yet. Be the first.

Post a comment

A free account is needed to post. Write your comment here first: your text is kept in this browser while you sign up or log in, and is waiting for you when you come back.

Your message:
|||||
10
Markdown: **bold**, *italic*, [text](https://link), - lists, > quotes, $x^2$ for math. Formatting help

Sign up and post (it is free)  or  Log in and post